Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
125 hedge funds and large institutions have $606M invested in Amedisys in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 55 reducing their positions, and 18 closing their positions.
287% more call options, than puts
Call options by funds: $4.59M | Put options by funds: $1.19M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more capital invested
Capital invested by funds: $519M → $606M (+$86.6M)
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
1% more funds holding
Funds holding: 124 → 125 (+1)
42% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$9.65M |
| 2 |
Millennium Management
New York
|
+$7.88M |
| 3 |
DCM
Decade Capital Management
New York
|
+$6.33M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$2.68M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.4M |
| 2 |
JP Morgan Chase
New York
|
-$7.69M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$6.1M |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$2.88M |
| 5 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$2.8M |
AMED Hedge Fund Activity: Q3 2014 in Review
125 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2014, worth a combined $606M — up 17% from $519M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new AMED positions and 18 closed out — a net gain of 2 holders — while 32 added to existing stakes and 55 trimmed.
The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $9.65M. The largest seller was Fidelity Investments, cutting an estimated $12.4M.
- 125 institutional investors held Amedisys (AMED) as of Q3 2014, up from 124 in Q2 2014.
- Funds reported $606M of Amedisys stock for Q3 2014, up 17% quarter-over-quarter.
- 20 funds opened new Amedisys positions in Q3 2014 and 18 closed out, a net change of +2 holders.
- The largest Amedisys buyer in Q3 2014 was EverPoint Asset Management, an estimated $9.65M added.
- The largest Amedisys seller in Q3 2014 was Fidelity Investments, an estimated $12.4M sold.
Based on aggregated 13F filings for Q3 2014.